Status: Not yet recruiting
Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer
The purpose of this study is to investigate the clinical efficacy and safety of darolutamide combined with androgen deprivation therapy (ADT) and different dose-intensity docetaxel chemotherapy in the treatment of patients with metastatic hormone-sensitive prostate cancer.
Participants needed: 50
Trial details
Age: 18+Biological sex: MaleType: ObservationalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Jun 22, 2025Duration: 1 Year
Eligibility criteria
Not listed